Exelixis (EXEL) Gross Profit (2012 - 2026)
Exelixis' (EXEL) quarterly Gross Profit came in at $590.9 million in Q2 2026, up 10.18% year-on-year from $536.3 million in Q2 2025, and up 3.26% quarter-over-quarter from $572.2 million in Q1 2026.
Exelixis (EXEL) Gross Profit (2012 - 2026) Analysis & Trends
Exelixis' Gross Profit history runs 15 years deep, the most recent figure standing at $590.9 million for Q2 2026.
- On a quarterly basis, Gross Profit rose 10.18% year-over-year to $590.9 million in Q2 2026; TTM through Apr 2026 was $2.3 billion, a 2.98% increase from a year earlier, with the FY2026 full-year figure at $2.2 billion, up 6.88% from the prior year.
- Gross Profit advanced to $590.9 million in Q2 2026 per EXEL's latest filing, from $572.2 million in the prior quarter.
- Across five years, Gross Profit topped out at $619.5 million in Q2 2024 and bottomed at $342.8 million in Q2 2022.
- The 5-year median for Gross Profit is $457.9 million (2023), against an average of $484.2 million.
- Across the five-year window, Gross Profit soared 37.02% in 2024 and fell 11.42% in 2025, its largest moves.
- Year by year, Gross Profit stood at $408.0 million in 2022, then climbed by 12.23% to $457.9 million in 2023, then increased by 14.05% to $522.2 million in 2024, then rose by 10.91% to $579.2 million in 2025, then advanced by 2.02% to $590.9 million in 2026.
- Per Business Quant, the three latest EXEL Gross Profit figures stand at $590.9 million (Q2 2026), $572.2 million (Q1 2026), and $579.2 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 590.86 Mn |
| Apr 3, 2026 | 590.86 Mn |
| Jan 2, 2026 | 572.18 Mn |
| Jan 2, 2026 | 572.18 Mn |
| Oct 3, 2025 | 579.18 Mn |
| Oct 3, 2025 | 579.18 Mn |
| Jul 4, 2025 | 548.79 Mn |
| Jul 4, 2025 | 548.79 Mn |
| Apr 4, 2025 | 536.28 Mn |
| Apr 4, 2025 | 536.28 Mn |
| Jan 3, 2025 | 546.79 Mn |
| Jan 3, 2025 | 546.79 Mn |
| Sep 27, 2024 | 522.21 Mn |
| Sep 27, 2024 | 522.21 Mn |
| Jun 28, 2024 | 619.51 Mn |
| Jun 28, 2024 | 619.51 Mn |
| Mar 29, 2024 | 403.97 Mn |
| Mar 29, 2024 | 403.97 Mn |
| Dec 29, 2023 | 457.90 Mn |
| Dec 29, 2023 | 457.90 Mn |